Patents
Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
04/2008
04/17/2008US20080090787 Thrombopoietin mimetics
04/17/2008US20080090785 Peptide-based compounds include at least three peptide units, an epoxide or aziridine, and functionalization at the N-terminus inhibit specific activities of N-terminal nucleophile (Ntn) hydrolases, e.g., the chymotrypsin-like activity of the 20S proteasome; antiproliferative and antiinflammatory agents
04/17/2008DE10234188B4 Oktupolare Moleküle als organische Halbleiter Octupolar molecules as organic semiconductors
04/17/2008DE102006048042A1 Acylaminoimidazole und Acylaminothiazole Acylaminoimidazole and Acylaminothiazole
04/17/2008CA2675511A1 N-aryl pyrazole compounds for use against diabetes
04/17/2008CA2665629A1 Heterocyclic derived metalloprotease inhibitors
04/17/2008CA2664579A1 2-aminocarbonyl-pyridine derivatives
04/16/2008EP1911757A2 Method of preparation of 3-(1,3-Dihydroimidazole-2-thione-1-yl)-chromanes and thiochromanes as dopamine-beta-hydroxylase inhibitors
04/16/2008EP1911754A1 Dipeptidyl peptidase inhibitors
04/16/2008EP1911747A1 Sulfonamide substituted pyrazoline compounds, their preparation and use as CB1 modulators
04/16/2008EP1910345A1 Substituted amides, their preparation and their use as pharmaceuticals
04/16/2008EP1910344A2 Indoline-substituted pyrazoline derivatives, their preparation and use as medicaments
04/16/2008EP1910330A1 Heterocyclylamide-substituted thiazoles, pyrroles and thiophenes
04/16/2008EP1910321A1 New compounds, process for their preparation, intermediates, pharmaceutical compositions and their use in the treatment of 5-ht6 mediated disorders such as alzheimer's disease, cognitive disorders, cognitive impairment associated with schizophrenia, obesity and parkinson's disease
04/16/2008EP1910310A1 Novelimidazolecarboxamide derivatives as fructose-1,6-bisphosphatase inhibitors, and pharmaceutical compositions comprising same
04/16/2008EP1910309A2 CYCLOALKYL AMINO-HYDANTOIN COMPOUNDS AND USE THEREOF FOR ß-SECRETASE MODULATION
04/16/2008EP1910308A1 Imidazole based lxr modulators
04/16/2008EP1910307A1 Pyrazole based lxr modulators
04/16/2008EP1909792A1 Substituted piperidine derivatives as somatostatin sst1 receptor antagonists
04/16/2008EP1578727B1 Tetrahydroquinoline derivatives and their use as fsh receptor modulators
04/16/2008EP1165549B1 C7 carbamoyloxy substituted taxanes as antitumor agents
04/16/2008CN101163696A Histone deacetylase inhibitors
04/16/2008CN101163478A Compounds for inflammation and immune-related uses
04/16/2008CN101161641A Tricyclic steroid hormone nuclear receptor modulators
04/16/2008CN100381937C Organophotoreceptor with charge transport material having a thiiranyl group
04/16/2008CN100381438C New pyrrolidine and thiazolidine compounds, process for their preparation and pharmaceutical compositions containing them
04/16/2008CN100381437C Compounds, compositions and methods
04/15/2008USRE40245 Gyrase inhibitors and uses thereof
04/15/2008US7358376 Substituted Thiophene compounds
04/15/2008US7358375 Low molecular weight conjugated nitrogen compounds and devices fabricated using the same
04/15/2008US7358276 2-Oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
04/15/2008US7358269 selective to alpha2B and/or alpha2C adrenergic receptors, minimal cardivascular and/or sedatory activity; pain
04/15/2008US7358261 Heteroaryl alkylamide derivatives useful as bradykinin receptor modulators
04/15/2008US7358257 sulfonylurea derivatives, sulfonylthiourea derivatives, sulfonylguanidine derivatives, sulfonylcyanoguanidine derivatives, thioacylsulfonamide derivatives, and acylsulfonamide derivatives; effective for prevention and treatment of cardiovascular diseases, antithrombotic agents
04/15/2008US7358014 Charge transport compounds of hydrazone substituted carbazole derivatives, a charge generating compound and electroconductive substrate
04/15/2008CA2411468C Thrombopoietin mimetics
04/10/2008WO2008040979A1 Arginine derivatives with np-i antagonistic activity
04/10/2008WO2008040097A1 Furanone compounds and lactam analogues thereof
04/10/2008WO2007143597A3 Organic compounds
04/10/2008US20080085900 Sulfonylguanidine compounds and pharmaceutical uses thereof
04/10/2008CA2664842A1 Arginine derivatives with np-i antagonistic activity
04/09/2008EP1908760A1 Chromane and thiochromane-3-yl-1,3-dihydroimidazoles as inhibitors of dopamine-beta-hydroxylase and methods of their preparation
04/09/2008EP1908759A2 3,4-dihydro-3-amino-2H-1-benzopyrane and -benzothiopyrane derivatives as dopamine-beta-hydroxylase Inhibitors and methods of their preparation
04/09/2008EP1907366A1 New imidazole derivatives, preparation method thereof and organic electronic device using the same
04/09/2008EP1907361A1 Amide derivatives as kinase inhibitors
04/09/2008EP1907359A2 3,5-substituted piperidine derivatives effective on renin-related disorders
04/09/2008EP1906964A1 Piperazinone derivatives useful as histamine h3 receptor antagonists and/or inverse agonists
04/09/2008EP1906962A2 Octahydroisoquinoline compounds as opioid receptor modulators
04/09/2008EP1594867B1 Phenylacetamides and their use as glucokinase modulators
04/09/2008EP1450796B1 Benzothiazole derivatives
04/09/2008EP1309565B1 Heterocyclic mutilin esters and their use as antibacterials
04/09/2008CN101160308A Methods of treating cancer and related methods
04/09/2008CN100379727C Substituted pyrazolyl benzenesulfonamides for the treatment of inflamation
04/09/2008CN100379415C Hetero biaryl derivatives as matrix metalloproteinase inhibitors
04/08/2008US7355775 Photochromic diarylethene-containing coordination compounds and the production thereof
04/08/2008US7355053 1-phenylpyrrolidine-2-one-3-carboxamides
04/08/2008US7355046 Chronic obstructive pulmonary dusease; asthma
04/08/2008US7354957 Multi-functional thioxanthone photoinitiators
04/08/2008US7354946 Biarylurea derivatives
04/08/2008US7354940 2,5-dioxoimidazolidin-4-yl acetamines and analogues as inhibitors of metalloproteinase mmp12
04/08/2008US7354931 Treating obstructive airway disorders using nontoxic drug
04/08/2008CA2232663C At1-receptor antagonists for preventing and treating postischemic renal failure and for protecting ischemic kidneys
04/03/2008WO2008038251A2 3-aza-bicyclo[3.1.0]hexane derivatives
04/03/2008WO2008038018A1 Novel minor groove binders
04/03/2008WO2008037789A1 Fungicide n-cycloalkyl-carboxamide, thiocarboxamide and n-substituted-carboximidamide derivatives
04/03/2008WO2008037784A1 Quinolinone derivatives
04/03/2008WO2008018639A3 Glycine transporter inhibitor
04/03/2008WO2008012234A3 Azolylmethyloxiranes, use thereof for controlling plant pathogenic fungi, and agents containing the same
04/03/2008WO2008008776A3 Hepatitis c virus inhibitors
04/03/2008WO2007086001A3 Novel pyridine derivatives
04/03/2008WO2007070359A3 Quinolone based compounds exhibiting prolyl hydroxylase inhibitory activity, and compositions, and uses thereof
04/03/2008US20080081907 5-HT5A serotonin receptor activity; such as (5-Methyl-furan-2-ylmethyl)-(5-phenoxymethyl-quinolin-2-yl)-amine; anxiety, depression, sleep disorders, schizophrenia
04/03/2008CA2664847A1 Novel minor groove binders
04/03/2008CA2662612A1 3-aza-bicyclo[3.1.0]hexane derivatives
04/03/2008CA2660377A1 Quinolinone derivatives
04/02/2008EP1905769A1 Heterocycle-substituted benzimidazole derivative
04/02/2008EP1905765A1 6-arylamino-5-cyano-4-pyrimidinone as PDE9A-inhibitors
04/02/2008EP1904488A1 Pyrazole compounds and thrombopoietin receptor activators
04/02/2008EP1904487A2 Indole derivatives for the treatment of tuberculosis
04/02/2008EP1904479A2 Novel 2,4-dianilinopyrimidine derivatives, the preparation thereof, their use as medicaments, pharmaceutical compositions and, in particular, as ikk inhibitors
04/02/2008EP1904476A1 Heteroaryl-substituted amides comprising an unsaturated or cyclic linker group, and their use as pharmaceuticals
04/02/2008EP1904473A1 Benzoheterocyclylethylcarboxamide derivatives
04/02/2008EP1904472A1 Thiophene compounds and thrombopoietin receptor activators
04/02/2008EP1904457A2 Compositions and methods for inhibition of the jak pathway
04/02/2008EP1904454A2 Process for the production of intermadiates for the preparation of tricyclic benzimidazoles
04/02/2008EP1904452A2 Histone deacetylase inhibitors
04/02/2008EP1904450A1 Pyrazole-4- carboxamide derivatives as microbiocides
04/02/2008EP1904446A2 Azabicyclo derivatives as muscarinic receptor antagonists
04/02/2008EP1904441A1 Process for producing cyano substituted arene boranes and compounds
04/02/2008EP1232147B1 Triazoles as farnesyl transferase inhibitors
04/02/2008CN101155804A Piperazine-substituted benzothiophenes for treatment of mental disorders
04/02/2008CN101155801A Process for preparing 2, 3-disubstituted indoles
04/02/2008CN101155800A Pyrazolylaminopyridine derivatives useful as kinase inhibitors
04/02/2008CN101155783A Pyrazoles
04/02/2008CN101155780A Hydroxamates as histone deacetylase inhibitors and pharmaceutical formulations containing them
04/02/2008CN101153022A Isoquinolinium compound, producing method and application of its salt
04/02/2008CN101153021A Isoquinolinium compound, producing method and application of its salt
04/02/2008CN100378098C Crystalline derivatives of 2-(5-chlorothien-2-yl)-n-((3s)-1((1s)-1-methyl-2-morpholin-4-yl)-2-oxoethyl)-2-oxopyrrolidin-3-yl)ethensulfonamide
04/02/2008CN100378092C Biphenyl derivatives
04/02/2008CN100378076C Pyridine carboxamide derivatives and their use as pesticides